Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Mativ Holdings
MATV
$711M
| $26.1M | ﹤0.01% |
782,056
-107,022
| -12% | -$3.22M |
|
1427
Genesco
GCO
$422M
| $26M | ﹤0.01% |
1,200,962
+169,894
| +16% | +$3.13M |
|
|
VIVO
1428
DELISTED
Meridian Bioscience Inc
VIVO
| $25.9M | ﹤0.01% |
1,110,089
+847,376
| +323% | +$12.3M |
|
1429
PJT Partners
PJT
$4.38B
| $25.8M | ﹤0.01% |
502,654
-236,911
| -32% | -$11.7M |
|
1430
Preferred Bank
PFBC
$1.25B
| $25.8M | ﹤0.01% |
602,202
+209,527
| +53% | +$7.71M |
|
1431
Invesco
IVZ
$13.9B
| $25.8M | ﹤0.01% |
2,396,813
-4,801,555
| -67% | -$43.1M |
|
1432
iShares S&P 100 ETF
OEF
$20.6B
| $25.8M | ﹤0.01% |
181,022
-4,417
| -2% | -$594K |
|
1433
AZZ Inc
AZZ
$4.54B
| $25.7M | ﹤0.01% |
749,331
+97,683
| +15% | +$2.99M |
|
|
NARI
1434
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $25.7M | ﹤0.01% |
+530,595
| New | +$25.3M |
|
1435
Vodafone
VOD
$37.4B
| $25.5M | ﹤0.01% |
1,602,452
+186,656
| +13% | +$2.82M |
|
1436
Allegion
ALLE
$14.4B
| $25.5M | ﹤0.01% |
249,833
+14,214
| +6% | +$1.4M |
|
|
GRTS
1437
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $25.5M | ﹤0.01% |
3,840,170
-1,402,901
| -27% | -$9.45M |
|
1438
Acadia Healthcare
ACHC
$2.94B
| $25.3M | ﹤0.01% |
1,008,913
+80,150
| +9% | +$2M |
|
|
ADAP
1439
DELISTED
Adaptimmune Therapeutics
ADAP
| $25.3M | ﹤0.01% |
2,523,783
+945,000
| +60% | +$5.93M |
|
1440
Exponent
EXPO
$3.24B
| $25.2M | ﹤0.01% |
311,938
-160,987
| -34% | -$11.6M |
|
1441
AMERISAFE
AMSF
$540M
| $25.1M | ﹤0.01% |
410,739
-195,322
| -32% | -$12.2M |
|
|
MRSN
1442
DELISTED
Mersana Therapeutics
MRSN
| $24.9M | ﹤0.01% |
42,592
+37,735
| +777% | +$12.9M |
|
1443
City Holding Co
CHCO
$2.04B
| $24.9M | ﹤0.01% |
381,611
-91,711
| -19% | -$5.81M |
|
|
SAFE
1444
DELISTED
Safehold Inc.
SAFE
| $24.6M | ﹤0.01% |
428,743
-54,943
| -11% | -$3.01M |
|
1445
Elanco Animal Health
ELAN
$11.1B
| $24.6M | ﹤0.01% |
1,147,769
+287,193
| +33% | +$6.34M |
|
1446
ScottsMiracle-Gro
SMG
$3.66B
| $24.6M | ﹤0.01% |
183,008
+6,982
| +4% | +$901K |
|
|
SCS
1447
DELISTED
Steelcase
SCS
| $24.5M | ﹤0.01% |
2,030,586
+982,583
| +94% | +$10.8M |
|
|
UMH
1448
UMH Properties
UMH
$1.36B
| $24.3M | ﹤0.01% |
1,882,872
-254,886
| -12% | -$3.08M |
|
1449
Teleflex
TFX
$5.98B
| $24.3M | ﹤0.01% |
66,863
+20,364
| +44% | +$7.04M |
|
|
EB
1450
DELISTED
Eventbrite
EB
| $24.3M | ﹤0.01% |
2,837,829
+2,312,684
| +440% | +$20.4M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.